1910 Genetics

1910 Genetics is building two AI-driven computational platforms, ROSALYND and ELVIS, to rapidly discover potential pharmaceutical drug molecules, hoping to cure and treat diseases that have thus far been incurable and undruggable.

Since 1910 Genetics’s technology is quite novel, the visual vocabulary we needed to express the applications and impact of their tech practically didn’t exist.

With this in mind, the main challenge we faced was building 1910’s visual vocabulary into a clear, accurate expression of their utilization of AI and machine learning — while accurately depicting the molecular biology that’s at the center of their approach.

Case study: https://www.fiftyseven.co/case/1910-genetics